Hormone-dependent cancers, particularly breast cancer, often rely on estrogen to grow and spread. Modern endocrine therapies focus on reducing estrogen production or blocking its activity to slow tumor progression. Among the most effective compounds used in hormone therapy are Anastrozole Tablets and Exemestane Tablets.
At Nova techsciences, we supply high-quality pharmaceutical compounds designed to support research and pharmaceutical development. Two important aromatase inhibitors in our portfolio include Anastrozole Tablets (CAS 120511-73-1) and Exemestane Tablets (CAS 107868-30-4), which are widely used in hormonal therapy strategies.
What Are Anastrozole Tablets (CAS 120511-73-1)?
Anastrozole Tablets are part of a class of medications known as aromatase inhibitors. The compound identified by CAS 120511-73-1 works by blocking the aromatase enzyme responsible for converting androgens into estrogen in the body. By inhibiting this process, the drug significantly reduces estrogen levels, which helps slow the growth of estrogen-dependent tumors.
Aromatase inhibitors like Anastrozole are commonly used in the treatment of estrogen receptor-positive breast cancer, particularly in postmenopausal women. The compound binds to the active site of the aromatase enzyme and prevents the biosynthesis of estrogen, depriving tumor cells of the hormone they require to grow.
Key Features of Anastrozole Tablets
- Active compound: CAS 120511-73-1
- Non-steroidal aromatase inhibitor
- Helps suppress estrogen production
- Commonly used in hormone-responsive breast cancer therapies
- Important compound in oncology research and pharmaceutical development
Due to its targeted action, Anastrozole Tablets have become an important component in endocrine therapy protocols. Pharmaceutical companies and research laboratories often source high-quality compounds from trusted suppliers such as Nova techsciences.
Exemestane Tablets (CAS 107868-30-4): A Steroidal Aromatase Inhibitor
Another widely studied aromatase inhibitor is Exemestane Tablets, identified by CAS 107868-30-4. Unlike some non-steroidal inhibitors, Exemestane is a steroidal aromatase inhibitor that works by permanently inactivating the aromatase enzyme.
Exemestane binds to the active site of aromatase and forms a covalent bond that renders the enzyme inactive. This irreversible inhibition leads to sustained suppression of estrogen production, which can help prevent the growth of estrogen-dependent tumors.
Key Characteristics of Exemestane Tablets
- Chemical identifier: CAS 107868-30-4
- Steroidal aromatase inhibitor
- Irreversibly inactivates the aromatase enzyme
- Used in hormone-dependent breast cancer therapy
- Highly studied compound in endocrine oncology research
Because of its unique mechanism of action, Exemestane Tablets are often explored in research and pharmaceutical development focused on hormonal cancer therapies.
Anastrozole vs Exemestane: Understanding the Difference
Both Anastrozole Tablets and Exemestane Tablets belong to the aromatase inhibitor category, but they differ in their chemical structure and mechanism.
| Feature | Anastrozole Tablets | Exemestane Tablets |
|---|---|---|
| Chemical Identifier | CAS 120511-73-1 | CAS 107868-30-4 |
| Drug Type | Non-steroidal aromatase inhibitor | Steroidal aromatase inhibitor |
| Mechanism | Reversibly inhibits aromatase enzyme | Irreversibly inactivates aromatase |
| Main Application | Hormone-responsive breast cancer | Hormone-dependent cancer therapies |
These differences allow healthcare professionals and researchers to select the most appropriate compound depending on the treatment strategy or research objective.
Why Choose Nova Techsciences?
When sourcing pharmaceutical compounds such as Anastrozole Tablets or Exemestane Tablets, quality assurance and consistency are essential.
Nova techsciences is committed to providing high-quality compounds that meet modern pharmaceutical and research standards. Our products are designed to support laboratories, pharmaceutical companies, and research institutions worldwide.
Our Advantages
-
High-purity pharmaceutical compounds
-
Strict quality control standards
-
Reliable global supply
-
Professional technical support
Our product portfolio includes high-quality hormone therapy compounds such as Anastrozole Tablets (CAS 120511-73-1) and Exemestane Tablets (CAS 107868-30-4).
Conclusion
Hormone therapy continues to play a vital role in the treatment of estrogen-dependent cancers. Compounds like Anastrozole Tablets and Exemestane Tablets help reduce estrogen levels in the body by inhibiting the aromatase enzyme, making them essential tools in modern endocrine oncology.
For pharmaceutical companies, research laboratories, and healthcare innovators, Nova techsciences offers trusted solutions. Whether sourcing Anastrozole Tablets (CAS 120511-73-1) or Exemestane Tablets (CAS 107868-30-4), partnering with a reliable supplier ensures consistent quality and dependable pharmaceutical compounds.
